SARS CoV 2 Infection

Showing 1 - 25 of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS CoV 2 Infection Trial (RIPH2)

Not yet recruiting
  • SARS CoV 2 Infection
  • RIPH2
  • (no location specified)
Nov 20, 2023

COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),

Not yet recruiting
  • COVID-19
  • +4 more
  • Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
  • Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
  • (no location specified)
Sep 29, 2023

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)

Not yet recruiting
  • SARS CoV 2 Infection
  • Influenza, Human
  • BIMERVAX
  • SIIV
  • Santiago De Compostela, A Coruña, Spain
  • +7 more
Aug 8, 2023

COVID-19 Transmission and Morbidity in Malawi

Recruiting
  • SARS CoV 2 Infection
  • SARS CoV 2 Vaccination
    • Boston, Massachusetts
    • +1 more
    Aug 6, 2023

    Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul

    Active, not recruiting
    • Respiratory Viral Infection
    • SARS CoV 2 Infection
      • Banjul, Western Region, Gambia
        Field study in the West Coast Region and Kanifing Municipality C
      Jul 11, 2023

      Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,

      Not yet recruiting
      • Influenza A
      • +3 more
      • Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
      • Raleigh, North Carolina
        Wake Med
      Jun 26, 2023

      SARS CoV 2 Infection Trial in Monastir (Spray with Hypochlorous Acid Group, Spray with Placebo Group)

      Recruiting
      • SARS CoV 2 Infection
      • Spray with Hypochlorous Acid Group
      • Spray with Placebo Group
      • Monastir, Tunisia
        Semir Nouira
      May 16, 2023

      Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With

      Active, not recruiting
      • COVID-19 Pneumonia
      • +4 more
        • Faro, Portugal
        • +1 more
        Apr 26, 2023

        COVID-19, Long COVID, Long Covid19 Trial in Paiporta, Valencia (Transcranial Direct Current Therapy (tDCS))

        Not yet recruiting
        • COVID-19
        • +12 more
        • Transcranial Direct Current Therapy (tDCS)
        • Paiporta, Valencia, Spain
        • +1 more
        Mar 21, 2023

        ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

        Recruiting
        • ME/CFS
        • +3 more
          • München, Germany
            München Klinik Schwabing
          Mar 20, 2023

          COVID-19, SARS CoV 2 Infection Trial (Prolectin-M)

          Not yet recruiting
          • COVID-19
          • SARS CoV 2 Infection
          • (no location specified)
          Feb 8, 2023

          Cognitive Decline, COVID-19, SARS CoV 2 Infection Trial in Hangzhou (hyperbaric oxygen therapy, conventional oxygen therapy)

          Not yet recruiting
          • Cognitive Decline
          • +2 more
          • hyperbaric oxygen therapy
          • conventional oxygen therapy
          • Hangzhou, Zhejiang, China
            First Affiliated Hospital of Zhejiang Chinese Medical University
          Feb 6, 2023

          NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of

          Recruiting
          • COVID-19
          • SARS CoV 2 Infection
            • New York, New York
              NYU Langone Health
            Jan 25, 2023

            SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)

            Enrolling by invitation
            • SARS CoV 2 Infection
            • COVID-19
            • Humoral immunity
            • Brussels, Belgium
              Sciensano
            Jan 16, 2023

            Cystic Fibrosis, Sickle Cell Disease, SARS CoV 2 Infection Trial in Irvine (Exercise)

            Recruiting
            • Cystic Fibrosis
            • +2 more
            • Exercise
            • Irvine, California
              University of California, Irvine
            Jan 5, 2023

            The Corona Study of Middle Norway

            Completed
            • SARS-CoV-2 Acute Respiratory Disease
            • +2 more
            • No intervention
            • Trondheim, MN, Norway
            • +4 more
            Dec 1, 2022

            COVID-19, Neuro-Degenerative Disease, Psychological Trial in Vigo, Ourense (Sessions of cognitive stimulation)

            Not yet recruiting
            • COVID-19
            • +3 more
            • Sessions of cognitive stimulation
            • Vigo, Pontevedra, Spain
            • +1 more
            Nov 29, 2022

            COVID-19, Fatigue, Distress Respiratory Syndrome Trial in Ourense, Vigo (Experimental tests)

            Not yet recruiting
            • COVID-19
            • +5 more
            • Experimental tests
            • Ourense, Spain
            • +6 more
            Nov 28, 2022

            SARS CoV 2 Infection, COVID-19 Trial in Los Angeles (Bemnifosbuvir (BEM), Placebo)

            Recruiting
            • SARS CoV 2 Infection
            • COVID-19
            • Bemnifosbuvir (BEM)
            • Placebo
            • Los Angeles, California
              Atea Study Site
            Nov 26, 2022

            COVID-19, SARS CoV 2 Infection Trial in Australia (NVX-CoV2515, NVX-Cov2373, NVX-CoV2373 + NVX-CoV2515)

            Active, not recruiting
            • COVID-19
            • SARS CoV 2 Infection
            • Bruce, Australian Capital Territory, Australia
            • +18 more
            Nov 23, 2022

            SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul

            Completed
            • SARS CoV 2 Infection
            • +3 more
              • Istanbul, Turkey
                Haseki Training and Research Hospital
              Nov 17, 2022

              COVID-19, SARS CoV 2 Infection Trial in Minneapolis (LumiraDX, RightSign, Case Control)

              Completed
              • COVID-19
              • SARS CoV 2 Infection
              • LumiraDX
              • +2 more
              • Minneapolis, Minnesota
                University of Minnesota
              Nov 18, 2022

              SARS CoV 2 Infection Trial in Newark (Testing for SARS CoV2 Antigen)

              Completed
              • SARS CoV 2 Infection
              • Testing for SARS CoV2 Antigen
              • Newark, New Jersey
                Rutgers School of Dental Medicine
              Nov 4, 2022

              SARS CoV 2 Infection Trial in Anniston, Hialeah (ASC10, Placebo)

              Not yet recruiting
              • SARS CoV 2 Infection
              • Anniston, Alabama
              • +1 more
              Oct 28, 2022